Publication
Evaluation of the UK Myeloma Research Alliance risk profile in transplant-ineligible multiple myeloma patients treated with novel agents.
Hitomi Nakayama, Tomonori Nakazato, Atsushi Takahata, Eriko Sato, Maho Kawakami, Keigo Okada, Takashi Abe, Toshiaki Hayashi, Kohtaro Toyama, Yasutaka Senpuku, Masaru Nakagawa, Motoki Takano, Keisuke Tanaka, Yuki Osada, Junichi Watanabe, Koh Yamamoto, Yasunobu Sekiguchi, Gaku Oshikawa, Yuta Kimura, Michihide Tokuhira, Ken Suzuki, Takayuki Ikezoe, Noriyoshi Iriyama, Katsuhiro Miura, Takashi Kumagai, Shigeo Toyota, Takehiko Mori
- Source
- PubMed
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20260908-000002
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
The heterogeneity of multiple myeloma (MM) significantly impacts treatment outcomes. Myeloma risk profile (MRP), introduced by the UK Myeloma Research Alliance, is a novel prognostic model for patients with transplant-ineligible newly diagnosed MM (TIE-NDMM) utilizing easily available clinical…
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Candidate 1
- cancerMultiple Myelomadictionary0.60
Curated evidence
Evidence citing this paper (0)
Data not yet available